Ultragenyx Pharmaceutical, Inc. (RARE)
23.00
+0.22
(+0.97%)
USD |
NASDAQ |
Dec 31, 16:00
22.93
-0.07
(-0.30%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Research and Development Expense (TTM): 699.19M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Amicus Therapeutics, Inc. | 142.29M |
| Geron Corp. | 81.32M |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Fortress Biotech, Inc. | 22.21M |